1. Drug Repurposing in Neurological Disorders: Implications for Neurotherapy in Traumatic Brain Injury. (December 2021) Authors: Shakkour, Zaynab; Habashy, Karl John; Berro, Moussa; Takkoush, Samira; Abdelhady, Samar; Koleilat, Nadia; Eid, Ali H.; Zibara, Kazem; Obeid, Makram; Shear, Deborah; Mondello, Stefania; Wang, Kevin K.; Kobeissy, Firas Journal: Neuroscientist Issue: Volume 27:Number 6(2021) Page Start: 620 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Inflammasomes as biomarkers and therapeutic targets in traumatic brain injury and related-neurodegenerative diseases: A comprehensive overview. (January 2023) Authors: Kattan, Dania; Barsa, Chloe; Mekhijian, Sarin; Shakkour, Zaynab; Jammoul, Maya; Doumit, Mark; Zabala, Maria Camila Pareja; Darwiche, Nadine; Eid, Ali H.; Mechref, Yehia; Wang, Kevin K.; de Rivero Vaccari, Juan Pablo; Munoz Pareja, Jennifer C.; Kobeissy, Firas Journal: Neuroscience and biobehavioral reviews Issue: Volume 144(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Thorough overview of ubiquitin C‐terminal hydrolase‐L1 and glial fibrillary acidic protein as tandem biomarkers recently cleared by US Food and Drug Administration for the evaluation of intracranial injuries among patients with traumatic brain injury. Issue 1 (19th January 2021) Authors: Wang, Kevin K.W.; Kobeissy, Firas H.; Shakkour, Zaynab; Tyndall, J. Adrian Journal: Acute medicine & surgery Issue: Volume 8:Issue 1(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗